LM, M., L, M., SJ, S., SM, T., & V, O. (2024). Targeting CD44 and other pleiotropic co-receptors as a means for broad inhibition of tumor growth and metastasis. Clinical & experimental metastasis, 41(5), 599. https://doi.org/10.1007/s10585-024-10292-4
Chicago Style (17th ed.) CitationLM, Mehner, Munoz-Sagredo L, Sonnentag SJ, Treffert SM, and Orian-Rousseau V. "Targeting CD44 and Other Pleiotropic Co-receptors as a Means for Broad Inhibition of Tumor Growth and Metastasis." Clinical & Experimental Metastasis 41, no. 5 (2024): 599. https://doi.org/10.1007/s10585-024-10292-4.
MLA (9th ed.) CitationLM, Mehner, et al. "Targeting CD44 and Other Pleiotropic Co-receptors as a Means for Broad Inhibition of Tumor Growth and Metastasis." Clinical & Experimental Metastasis, vol. 41, no. 5, 2024, p. 599, https://doi.org/10.1007/s10585-024-10292-4.